Annual Long Term Debt
$117.60 K
-$122.20 K-50.96%
June 1, 2024
Summary
- As of February 24, 2025, NEUP annual long term debt is $117.60 thousand, with the most recent change of -$122.20 thousand (-50.96%) on June 1, 2024.
- During the last 3 years, NEUP annual long term debt has fallen by -$403.50 thousand (-77.43%).
Performance
NEUP Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
$49.80 K
-$39.70 K-44.36%
December 1, 2024
Summary
- As of February 24, 2025, NEUP quarterly long term debt is $49.80 thousand, with the most recent change of -$39.70 thousand (-44.36%) on December 1, 2024.
- Over the past year, NEUP quarterly long term debt has stayed the same.
Performance
NEUP Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
NEUP Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -51.0% | 0.0% |
3 y3 years | -77.4% | - |
5 y5 years | -98.1% | -98.6% |
NEUP Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -77.4% | at low | -88.8% | at low |
5 y | 5-year | -98.1% | at low | -98.8% | at low |
alltime | all time | -99.1% | -93.3% | -99.6% | -84.1% |
Neuphoria Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $49.80 K(-44.4%) |
Sep 2024 | - | $89.50 K(-23.9%) |
Jun 2024 | - | $117.63 K(-36.6%) |
Jun 2024 | $117.60 K(-51.0%) | - |
Dec 2023 | - | $185.40 K(-22.7%) |
Jun 2023 | $239.80 K(-34.7%) | $239.80 K(-21.4%) |
Dec 2022 | - | $305.20 K(-16.9%) |
Jun 2022 | $367.10 K(-29.6%) | $367.10 K(-17.6%) |
Dec 2021 | - | $445.50 K(-14.5%) |
Jun 2021 | $521.10 K(-87.9%) | $521.10 K(-70.2%) |
Dec 2020 | - | $1.75 M(-59.5%) |
Jun 2020 | $4.32 M(-28.7%) | $4.32 M(+20.3%) |
Dec 2019 | - | $3.59 M(-40.7%) |
Jun 2019 | $6.06 M(-47.6%) | $6.06 M(-31.4%) |
Dec 2018 | - | $8.83 M(-23.6%) |
Jun 2018 | $11.56 M(+50.2%) | $11.56 M(-18.7%) |
Dec 2017 | - | $14.23 M(+84.9%) |
Jun 2017 | $7.70 M(-44.1%) | $7.70 M(-27.8%) |
Dec 2016 | - | $10.66 M(-22.6%) |
Jun 2016 | $13.77 M(+92.7%) | $13.77 M(+38.2%) |
Dec 2015 | - | $9.96 M(+39.4%) |
Jun 2015 | $7.15 M(+1401.0%) | $7.15 M(-22.5%) |
Dec 2014 | - | $9.22 M(+1837.2%) |
Jun 2014 | $476.10 K(+30.4%) | $476.10 K(+58.2%) |
Dec 2013 | - | $301.00 K(-17.6%) |
Jun 2013 | $365.20 K | $365.20 K(-8.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | - | $397.60 K(-12.5%) |
Jun 2012 | $454.30 K(+5650.6%) | $454.30 K(+10.5%) |
Dec 2011 | - | $411.10 K(+5103.8%) |
Jun 2011 | $7900.00(-99.7%) | $7900.00(-99.7%) |
Dec 2010 | - | $2.54 M(+11.1%) |
Jun 2010 | $2.29 M(-10.4%) | $2.29 M(-12.3%) |
Dec 2009 | - | $2.61 M(+2.1%) |
Jun 2009 | $2.55 M(-24.5%) | $2.55 M(+9.2%) |
Dec 2008 | - | $2.34 M(-30.9%) |
Jun 2008 | $3.38 M(+2.9%) | $3.38 M(+2.0%) |
Dec 2007 | - | $3.32 M(+0.9%) |
Jun 2007 | $3.29 M(+11.7%) | $3.29 M(+11.2%) |
Dec 2006 | - | $2.96 M(+0.5%) |
Jun 2006 | $2.94 M(-10.0%) | $2.94 M(-1.9%) |
Dec 2005 | - | $3.00 M(-8.2%) |
Jun 2005 | $3.27 M(+2.2%) | $3.27 M(-8.4%) |
Dec 2004 | - | $3.57 M(+11.6%) |
Jun 2004 | $3.20 M(+3.8%) | $3.20 M(-7.1%) |
Dec 2003 | - | $3.44 M(+11.7%) |
Jun 2003 | $3.08 M(+9.4%) | $3.08 M(+16.9%) |
Dec 2002 | - | $2.64 M(-6.4%) |
Jun 2002 | $2.82 M(>+9900.0%) | $2.82 M(>+9900.0%) |
Jun 2001 | $25.50 K(-14.7%) | $25.50 K(-8.3%) |
Dec 2000 | - | $27.80 K |
Jun 2000 | $29.90 K(-10.5%) | - |
Jun 1999 | $33.40 K | - |
FAQ
- What is Neuphoria Therapeutics annual long term debt?
- What is the all time high annual long term debt for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual long term debt year-on-year change?
- What is Neuphoria Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly long term debt year-on-year change?
What is Neuphoria Therapeutics annual long term debt?
The current annual long term debt of NEUP is $117.60 K
What is the all time high annual long term debt for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual long term debt is $13.77 M
What is Neuphoria Therapeutics annual long term debt year-on-year change?
Over the past year, NEUP annual long term debt has changed by -$122.20 K (-50.96%)
What is Neuphoria Therapeutics quarterly long term debt?
The current quarterly long term debt of NEUP is $49.80 K
What is the all time high quarterly long term debt for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly long term debt is $14.23 M
What is Neuphoria Therapeutics quarterly long term debt year-on-year change?
Over the past year, NEUP quarterly long term debt has changed by $0.00 (0.00%)